Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Does aTyr Pharma Inc (LIFE) Stack Up Against Its Peers?

Page 1 of 2

A whopping number of 13F filings filed with U.S. Securities and Exchange Commission has been processed by Insider Monkey so that individual investors can look at the overall hedge fund sentiment towards the stocks included in their watchlists. These freshly-submitted public filings disclose money managers’ equity positions as of the end of the three-month period that ended September 30, so let’s proceed with the discussion of the hedge fund sentiment on aTyr Pharma Inc. (NASDAQ:LIFE).

aTyr Pharma Inc (NASDAQ:LIFE) investors should be aware of an increase in hedge fund sentiment lately. There were 5 hedge funds in our database with LIFE holdings at the end of the second quarter, which rose to 6 by the end of the third quarter. The level and the change in hedge fund popularity aren’t the only variables you need to analyze to decipher hedge funds’ perspectives. A stock may witness a boost in popularity but it may still be less popular than similarly priced stocks. That’s why at the end of this article we will examine companies such as UniPixel Inc (NASDAQ:UNXL), Sito Mobile Ltd (NASDAQ:SITO), and Galena Biopharma Inc (NASDAQ:GALE) to gather more data points.

Follow Life Technologies Corp (NASDAQ:LIFE)
Trade (NASDAQ:LIFE) Now!

At Insider Monkey, we’ve developed an investment strategy that has delivered market-beating returns over the past 12 months. Our strategy identifies the 100 best-performing funds of the previous quarter from among the collection of 700+ successful funds that we track in our database, which we accomplish using our returns methodology. We then study the portfolios of those 100 funds using the latest 13F data to uncover the 30 most popular mid-cap stocks (market caps of between $1 billion and $10 billion) among them to hold until the next filing period. This strategy delivered 18% gains over the past 12 months, more than doubling the 8% returns enjoyed by the S&P 500 ETFs.

pharmacist, medical, retail, worker, team, young, staff, lab, chemistry, business, drug, chemist, adult, teamwork, internet, male, drugstore, service,

wavebreakmedia/Shutterstock.com

How have hedgies been trading aTyr Pharma Inc. (NASDAQ:LIFE)?

Heading into the fourth quarter of 2016, a total of 6 of the hedge funds tracked by Insider Monkey were long this stock, a 20% rise from one quarter earlier. By comparison, 9 hedge funds held shares or bullish call options in LIFE heading into this year, so hedge fund ownership of the stock is still down by 33% in 2016. So, let’s find out which hedge funds were among the top holders of the stock and which hedge funds were making big moves.

life

According to Insider Monkey’s hedge fund database, Anand Parekh’s Alyeska Investment Group has the most valuable position in aTyr Pharma Inc. (NASDAQ:LIFE), worth close to $3.3 million. The second most bullish fund manager is Rock Springs Capital Management, led by Kris Jenner, Gordon Bussard, and Graham McPhail, which holds a $1.4 million position. Remaining peers that hold long positions contain Kevin C. Tang’s Tang Capital Management, Alec Litowitz and Ross Laser’s Magnetar Capital, and Renaissance Technologies, one of the largest hedge funds in the world. We should note that none of these hedge funds are among our list of the 100 best performing hedge funds, which is based on the performance of their 13F long positions in non-micro-cap stocks.

Page 1 of 2